Trial Profile
Effect of atorvastatin monotherapy and low-dose atorvastatin/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipidemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Mar 2012
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Atorvastatin/ezetimibe (Primary)
- Indications Hyperlipoproteinaemia type IIb
- Focus Therapeutic Use
- 08 Mar 2012 New trial record